Drugplain

Butalbital, aspirin, and caffeine 325 mg/1

Butalbital, aspirin, and caffeine · CAPSULE · Sandoz Inc

No Recall History
Plain English

Butalbital, aspirin, and caffeine is a capsule containing butalbital, aspirin, and caffeine at 325 mg/1, taken oral. Manufactured by Sandoz Inc.

Key Facts

Brand Name
Butalbital, aspirin, and caffeine
Generic Name
Butalbital, aspirin, and caffeine
NDC Code (Product)
0781-2270
Manufacturer
Sandoz Inc
Strength
325 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
DEA Schedule
Schedule III (Controlled)
Application #
ANDA086996
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
Marketing Start
09/03/2024

Recall History

No Recall History

Frequently Asked Questions

What is Butalbital, aspirin, and caffeine used for?

Butalbital, aspirin, and caffeine contains Butalbital, aspirin, and caffeine. It is a capsule taken oral. Consult your doctor for specific uses.

Is Butalbital, aspirin, and caffeine a controlled substance?

Yes, Butalbital, aspirin, and caffeine is classified as CIII under the DEA Controlled Substances Act.

What is the generic name for Butalbital, aspirin, and caffeine?

The generic name for Butalbital, aspirin, and caffeine is Butalbital, aspirin, and caffeine. There are 3 other brand versions of Butalbital, aspirin, and caffeine.

What is the NDC code for Butalbital, aspirin, and caffeine 325 mg/1?

The NDC (National Drug Code) for Butalbital, aspirin, and caffeine 325 mg/1 is 0781-2270, listed by Sandoz Inc.

Product NDC

0781-2270

Package NDC

0781-2270-01

Other Butalbital, aspirin, and caffeine Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)